The mitogen-activated protein kinase (MAPK) p38 modulates a variety of cell
ular functions, including proliferation, differentiation and cell death. Ho
wever, we report here a novel function for p38, i.e. the regulation of cyto
toxic lymphocyte-mediated cytotoxicity. Stimulation of NK cells by either c
ross-linking of their Fc gamma RIII receptors or by binding to NK-sensitive
target cells induces the phosphorylation and activation of p38, and also o
f its upstream regulators MKK3/MKK6. Pharmacologic analyses suggest that Sr
c-family and Syk-family protein tyrosine kinases couple the NK cell surface
receptors to p38 activation. The role of p38 in the cytotoxic function of
NK cells was tested by treatment of NK cells with the cell-permeable, p38-s
pecific inhibitor SB203580. Interestingly, exposure to the drug reduced bot
h antibody dependent cellular cytotoxicity and natural cytotoxicity, but ma
ximal inhibitory concentrations resulted in only partial inhibition. Collec
tively, these results suggest that the p38 MAPK pathway is stimulated durin
g the development of NK cell-mediated cytotoxicity and that efficient killi
ng is influenced by both p38-dependent and p38-independent pathways. More b
roadly, this study identifies the regulation of cell-mediated killing as a
novel role for p38 in cytotoxic lymphocytes.